Archives
- 2025-11
 - 2025-10
 - 2025-09
 - 2025-03
 - 2025-02
 - 2025-01
 - 2024-12
 - 2024-11
 - 2024-10
 - 2024-09
 - 2024-08
 - 2024-07
 - 2024-06
 - 2024-05
 - 2024-04
 - 2024-03
 - 2024-02
 - 2024-01
 - 2023-12
 - 2023-11
 - 2023-10
 - 2023-09
 - 2023-08
 - 2023-07
 - 2023-06
 - 2023-05
 - 2023-04
 - 2023-03
 - 2023-02
 - 2023-01
 - 2022-12
 - 2022-11
 - 2022-10
 - 2022-09
 - 2022-08
 - 2022-07
 - 2022-06
 - 2022-05
 - 2022-04
 - 2022-03
 - 2022-02
 - 2022-01
 - 2021-12
 - 2021-11
 - 2021-10
 - 2021-09
 - 2021-08
 - 2021-07
 - 2021-06
 - 2021-05
 - 2021-04
 - 2021-03
 - 2021-02
 - 2021-01
 - 2020-12
 - 2020-11
 - 2020-10
 - 2020-09
 - 2020-08
 - 2020-07
 - 2020-06
 - 2020-05
 - 2020-04
 - 2020-03
 - 2020-02
 - 2020-01
 - 2019-12
 - 2019-11
 - 2019-10
 - 2019-09
 - 2019-08
 - 2019-07
 - 2019-06
 - 2019-05
 - 2019-04
 - 2018-07
 
- 
                
          
br Materials and methods br
2021-04-17

Materials and methods Results Discussion We initially found that ISL, a natural product with a linear scaffold (2-propenone), is able to inhibit CK2 (IC50 = 17.3 μM). Then we have investigated the inhibitory potential of a novel series of compounds with linear scaffolds by combining fragmen
 - 
                
          
Patients and methods This study was performed
2021-04-17

Patients and methods This study was performed at 3 academic centers (Chung-Ang University YongSan Hospital, Soonchunhyang University Hospital, and Chung-Ang University Hospital) in Seoul, Korea, from November 2008 to November 2010. The study protocol was approved by the institutional review boards
 - 
                
          
br EphB as a therapeutic target in
2021-04-17

EphB4 as a therapeutic target in cancer Eph receptors and ephrins are promising new therapeutic targets in cancer. Various strategies have been employed to evaluate the interference of tumor-promoting effects or the enhancement of tumor suppressive effects. The inhibition of the Eph-ephrin system
 - 
                
          
EC barrier dysfunction triggered by inflammatory mediators i
2021-04-17

EC barrier dysfunction triggered by inflammatory mediators involves more than one mechanism, explaining the partial attenuation of EC barrier compromise obtained with PKA and Epac activators. PKA-dependent phosphorylation of vasodilator-stimulated phosphoprotein (VASP) has been shown to make a posit
 - 
                
          
Two GPCR subtypes of interest in the
2021-04-17

Two GPCR subtypes of interest in the myocardium are the endothelin receptor (ETR) and the α1-adrenergic receptor (α1-AR). Upon ligand binding, these receptors canonically activate the Gαq protein leading to activation of phospholipase C, hydrolysis of phosphatidylinositol 4,5-bisphosphate into diacy
 - 
                
          
The endothelin receptor type B EDNRB belongs to the family
2021-04-17

The endothelin receptor type B (EDNRB) belongs to the family of G protein-coupled receptors, which functions as a vital regulatory factor in signal transduction in cells, locating on human chromosome 13q22.3 (Ayala-Valdovinos et al., 2016; Bregar et al., 2018; Morimoto et al., 2018; Widowati et al.,
 - 
                
          
In conclusion we provide convincing evidence that the PRRSV
2021-04-17

In conclusion, we provide convincing evidence that the PRRSV-induced SGs are indeed bona fide SGs. While we determined that mRNA is present in the PRRSV-induced SGs, we did not distinguish its origin. Future studies will need to determine whether the mRNA stored in PRRSV-induced SGs is of cellular o
 - 
                
          
br Materials and methods br Results
2021-04-17

Materials and methods Results Among 17,061 probes, the poly ic of 758 probes (4.4%) showed at least a 2-fold upregulation (230 probes) or downregulation (528 probes) at day 3 after VMH lesioning as compared with sham-VMH lesioning. Supplement Table 1 shows the upregulated (>2-fold) and the do
 - 
                
          
br Introduction A variety of means
2021-04-17

Introduction A variety of means, including UV irradiation, dNTP depletion, and oncogene activation at precancerous lesions, induce replication stress, which causes replication errors if left undealt with (Hills and Diffley, 2014, Zeman and Cimprich, 2014). Eukaryotic cells have developed the DNA
 - 
                
          
The involvement of FOXO and STAT in
2021-04-17

The involvement of FOXO3 and STAT5 in DNA-PKcs and gpr109a inhibitor IV has not been reported before, and the search by the ECR browser (http://ecrbrowser.decode.org) revealed that 1kb of the 5′ promoter of DNA-PKcs possesses 4 STAT (−908bp to −901bp, −676bp to −656bp, −533bp to −526bp and −66bp to
 - 
                
          
telomerase inhibitors As for antiviral activity eight out of
2021-04-17

As for antiviral activity, eight out of 23 synthesized compounds were active against influenza B virus with EC50 values in the range of 0.19–39 μM. Four of the eight influenza B hits were active against influenza A and two were also active against RSV (4 and 6, EC50 = 0.40 and 1.8 μM, respectively).
 - 
                
          
One of the features of ROCO
2021-04-17

One of the features of ROCO proteins, controlled by their domain architecture is their oligomerization status. By size-exclusion chromatography and Western blot analysis, DAPK1 was proved to form homodimers via its GTPase and kinase domains [53]. Similarly, BTZ043 Racemate mg microscopy studies con
 - 
                
          
Thiazovivin br Proteases with special focus on cysteine
2021-04-17

Proteases with special focus on cysteine proteases Vaccination using cysteine proteases as antigens with special emphasis on DNA-vaccines Concluding remarks In spite of the great potential of DNA vaccines, the technology has not been as revolutionary as expected in higher mammals. In fish,
 - 
                
          
To elucidate the potential mechanism
2021-04-17

To elucidate the potential mechanism underlying osteosarcoma cell growth decrease by CDK4 inhibition, flow cytometry analysis was used to determine DBU and apoptosis in human osteosarcoma cells after palbociclib treatment. The results showed that osteosarcoma cells were arrested in G1 phase of the
 - 
                
          
br Additional CDKs with a role
2021-04-17

Additional CDKs with a role in cancer Small molecule CDK inhibitors The majority of protein kinase inhibitors developed to date are type I inhibitors: they bind at the ATP–binding site, are ATP-competitive and target the kinase in its active state; with the activation loop DFG motif in the ‘in
 
16123 records 698/1075 page Previous Next First page 上5页 696697698699700 下5页 Last page